Guangxi Wuzhou Zhongheng Group Co., Ltd (SHSE: 600252)
Health Care · Pharmaceuticals · CN
CN¥2.22
-3.48% today · -22.6% 1Y
Guangxi Wuzhou Zhongheng Group Co., Ltd (SHSE: 600252) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.05B and employs 2,843 people.
Over the last twelve months the share price has lost 22.6%, trading between 1.71 and 3.10.
Tweenvest scores Guangxi Wuzhou Zhongheng Group Co., Ltd across four factors: quality 60/100, value 39/100, growth 0/100. Its strongest factor is quality.
600252 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.05B
- Revenue (TTM)
- $229.34M
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- CN¥3.10
- 52-week low
- CN¥1.71
- Avg volume (3M)
- —
- Shares outstanding
- 3.18B
- Employees
- 2,843
- Next earnings
- —
About Guangxi Wuzhou Zhongheng Group Co., Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd., operating from Wuzhou, China, specializes in the research, development, manufacturing, and distribution of pharmaceutical products across the nation. The company's diverse range of medicinal preparations includes pills, capsules, injections, and tablets, formulated to address various health concerns such as cardiovascular and cerebrovascular disorders, physical injuries, gynecological conditions, and respiratory ailments. In addition to its core pharmaceutical business, Guangxi Wuzhou Zhongheng Group also produces health food items, notably under its DOUBLE MONEY brand. Furthermore, its offerings encompass health-oriented functional beverages, various forms of turtle paste (including smokable and jelly types), and other related wellness products.
- ISIN
- CNE0000015F9
- Founded
- 1993
- Listed since
- Nov 30, 2000
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.